AzTrials
AzTrials

Pain, ChronicNCT05247892

Effectiveness of Ultrasound Versus Fluoroscopy Guided S1 Injections and Radiofrequency

A study testing Ultrasound-guided S1 Radiofrequency stimulation and Fluoroscopic-guided S1 Radiofrequency stimulation in people with Pain, Chronic, run by Diskapi Teaching and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators aim to compare the effect of ultrasound versus floroscopy guided pulsed radiofrequency treatment of the lumbar dorsal root ganglion (DRG) of S1 in patients with a chronic lumbosacral radicular pain. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain, Chronic
What is being tested?
Ultrasound-guided S1 Radiofrequency stimulation and Fluoroscopic-guided S1 Radiofrequency stimulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2022to 20 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Persistent pain score ≥ 4 on VAS, not responding to traditional treatments
  • Radicular pain in lumbar region for 3 months or more,
  • Pattern of radiation suggestive for S1 pathology

Who cannot join

  • Patient refusal
  • Coagulopathy
  • Uncooperative patients
  • Malignant disorder or currently under treatment for a malignant disorder
  • Pregnancy
  • Leg pain due to localized hip or knee pathology

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Diskapi Yildirim Beyazit Training and Research Hospital

    Ankara, 06110

Other trials in Turkey (Türkiye)

About this study

Official title: Effectiveness of Ultrasound Versus Fluoroscopy Guided S1 Injections and Radiofrequency for the Management of Radicular Pain

The investigators aim to compare the effect of ultrasound versus floroscopy guided pulsed radiofrequency treatment of the lumbar dorsal root ganglion (DRG) of S1 in patients with a chronic lumbosacral radicular pain.

Conditions
Pain, Chronic
Being tested
Ultrasound-guided S1 Radiofrequency stimulation, Fluoroscopic-guided S1 Radiofrequency stimulation
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound-guided S1 Radiofrequency stimulationProcedure or surgery

    Pulsed radiofrequency stimulation of the S1 dorsal root ganglia under ultrasound-guidance

  • Fluoroscopic-guided S1 Radiofrequency stimulationProcedure or surgery

    Pulsed radiofrequency stimulation of the S1 dorsal root ganglia under fluoroscopy-guidance

Study groups in NCT05247892
Study groupRoleWhat they receive
Fluoroscopic-guided S1 Radiofrequency stimulationActive comparatorNot described
Receives: Procedure: Fluoroscopic-guided S1 Radiofrequency stimulation
Ultrasound-guided S1 Radiofrequency stimulationExperimentalNot described
Receives: Procedure: Ultrasound-guided S1 Radiofrequency stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain scores

    Visual analog scale (VAS) for pain at the follow-up time periods. The visual analog scale is a numerical scale from 0 to 10; with 0 representing no pain and 10 representing the worst pain imaginable.

    Measured: baseline to 6 months post-procedure

Secondary outcomes (2)
  1. Oswestry Disability Index (ODI)

    Mean Change from Baseline in functional disability scores based on Oswestry Disability Index. 0% to 20% indicate minimal disability, 21% to 40% indicate moderate disability, 41%-60% indicates severe disability, 61%-80% means crippled and 81%-100% indicates that the patient is either bed-bound or exaggerating his/her symptoms.

    Measured: baseline to 6 months post-procedure

  2. Patient satisfaction Questionnaire

    Satisfaction was measured on a 1 to 5 scale,Using score: 5-Excellent, 4-Very Good, 3-Good, 2-Fair, and 1-Poor

    Measured: baseline to 6 months post-procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2022
  2. Study start1 Feb 2022
  3. Primary completion10 Oct 2022
  4. Study completion20 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05247892
Sponsor's protocol ID
121/12
Status last verified
Oct 2022
First submitted
1 Feb 2022
Last updated
2 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound-guided S1 Radiofrequency stimulation and Fluoroscopic-guided S1 Radiofrequency stimulation in people with Pain, Chronic, run by Diskapi Teaching and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain scores (time frame: baseline to 6 months post-procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in